Shareholders' Equity |
12 Months Ended |
|---|---|
Jan. 29, 2022 | |
| Shareholders' Equity [Abstract] | |
| Shareholders' Equity |
Note 8. Shareholders’ Equity
The Company classifies repurchased shares as treasury stock on the Company’s Consolidated Balance Sheet. There were no treasury stock repurchases during fiscal 2021 and fiscal 2020.
During fiscal 2021, 9,000 shares
were issued to Directors and employees. During fiscal 2021, 138,418 warrants were exercised for proceeds of $1,384.
On March 18, 2021, the Company closed an underwritten offering of 416,600 shares of common stock of the Company, at a price to the public of $32.50
per share. The gross proceeds of the offering were approximately $13.5 million, prior to deducting underwriting discounts and
commissions and estimated offering expenses.
During fiscal 2020, 9,949 shares were issued to
Directors and employees. Of the shares issued, 1,062 were returned to the company to satisfy withholding requirements and retired to
treasury shares. During fiscal 2020, 100,988 warrants were exercised for proceeds of $1,010.
No cash dividends were paid in
fiscal 2021 and fiscal 2020.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|